Document is current
Any future updates will be listed below
-
Authors
Zhang, Yi https://orcid.org/0000-0002-7453-6188
Liu, Yang
Liu, X. Shirley https://orcid.org/0000-0003-4736-7339
- License Information
-
More Information
Article History
First Online: 7 May 2021
Competing interests
: X.S.L. is a cofounder, board member, SAB, and consultant of GV20 Oncotherapy and its subsidiaries, SAB of 3DMedCare, consultant for Genentech, and stockholder of AMGN, JNJ, MRK, PFE, and receives sponsored research funding from Takeda and Sanofi.
